Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials


Journal Article

Clinical evidence have shown SBRT to be a tolerable, efficacious, and promising non-invasive therapy. Randomized prospective studies comparing surgery vs. SBRT in early-stage lung cancer are proposed to further investigate the relative survival, quality of life, and cost characteristics of these treatment paradigms. Accreditation and dosimetry requirements were carefully vetted for RTOG SBRT trials. Advanced technologies introduced since have posed additional challenges. This study provides an overview of the quality requirements including those for the recently introduced technologies. © 2013 Springer-Verlag.

Full Text

Duke Authors

Cited Authors

  • Xiao, Y; Yin, F; Kong, FMS; Yue, J; Galvin, J

Published Date

  • April 16, 2013

Published In

Volume / Issue

  • 39 IFMBE /

Start / End Page

  • 2284 - 2287

International Standard Serial Number (ISSN)

  • 1680-0737

Digital Object Identifier (DOI)

  • 10.1007/978-3-642-29305-4_599

Citation Source

  • Scopus